Stay updated on Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page.

Latest updates to the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice announces the transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference0.8%

- Check8 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check35 days agoChange DetectedA new revision entry v3.7.0 is added to the history, and the previous revision v3.6.6 is removed, updating the set of revisions shown for this study. This reflects the latest versioning of the study record in ClinicalTrials.gov.SummaryDifference0.1%

- Check56 days agoChange DetectedThe Record History gains a new revision entry labeled v3.6.6, replacing the prior v3.6.5.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the Record History, and the previous 'Revision: v3.6.4' entry was removed. This update records the latest revision to the study record.SummaryDifference0.1%

Stay in the know with updates to Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page.